Stocks and Investing Stocks and Investing
Fri, May 3, 2024
Thu, May 2, 2024

Ami Fadia Reiterated (BPMC) at Strong Buy and Held Target at $97 on, May 2nd, 2024


Published on 2024-10-28 10:52:22 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $97 on, May 2nd, 2024.

Ami has made no other calls on BPMC in the last 4 months.



There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024


These are the ratings of the 5 analyists that currently disagree with Ami


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $125 on, Friday, April 26th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Wednesday, April 10th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024